Clinical Genomics Pipeline: From Sample to Report

Overview of the Clinical Genomics Pipeline

The clinical genomics pipeline is a series of steps that transform raw genomic data into actionable insights for diagnosis, treatment, and monitoring of diseases. It starts with sample collection, followed by extraction of nucleic acids, sequencing to generate millions of reads, quality control (QC) filtering to remove low-quality data, variant calling to identify genetic variations, and finally, reporting the results to clinicians.

Each step in this pipeline is critical for ensuring accurate and reliable genomic information. For instance, sequencing depth determines the number of times each base pair is sequenced, which affects the detection of rare variants; variant allele fraction (VAF) indicates the proportion of reads supporting a variant over the total reads, crucial for distinguishing true variants from noise; and Phred quality threshold filters out low-confidence bases to improve overall data quality.

Impact of Sequencing Depth

Sequencing depth is a key parameter that influences both the detection of rare genetic variants and the overall accuracy of variant calling. Higher sequencing depths increase the sensitivity for detecting low-frequency mutations but also require more computational resources and can introduce biases if not properly managed.

For example, in cancer genomics, where somatic mutations are often present at very low frequencies (VAFs < 1%), increasing sequencing depth helps to identify these rare events with greater confidence. However, too high a depth can lead to overestimation of variant frequency and increased false positive rates.

Role of Variant Allele Fraction

The variant allele fraction (VAF) is a critical metric in genomics that reflects the proportion of reads supporting a genetic variant. It helps in distinguishing true variants from sequencing errors or technical artifacts, especially when dealing with low-frequency mutations.

In clinical diagnostics, accurately estimating VAF is essential for interpreting results correctly. For instance, in hereditary cancer syndromes like Lynch syndrome, where germline mutations are common but often present at very low VAFs (1-5%), precise VAF estimation can be the difference between a positive and negative test result.

Quality Control and Variant Calling

Quality control (QC) filtering is an essential step in the genomics pipeline that removes low-quality reads, which are more likely to introduce errors or bias into variant calling. QC thresholds can be set based on various metrics such as base quality scores, mapping quality, and sequence context.

Phred quality threshold, a widely used metric for assessing the confidence of base calls, plays a crucial role in filtering out low-confidence bases. For example, setting a Phred Q20 threshold means that only reads with an expected error rate below 1% are retained. This helps in maintaining high-quality data but may also result in loss of some true variants if they fall just below the threshold.

Frequently asked questions

Try it live

Everything above runs in your browser — open Clinical Genomics Pipeline Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.